POU5F1 and cancer: We have reported that oncolytic adenoviruses driven by the Oct4 promoter or Oct4 response element (ORE) exert antitumor activities against blander cancer that expresses Oct4, validating Oct4 as a potential therapeutic target for cancer [12, 15].